Circadian Disruption Impacts Pregnant Mothers & Fetuses

A 2022 study “Evening blue‐light exposure, maternal glucose, and infant birthweight” investigated whether exposure to blue‐enriched light in the evening during late pregnancy is linked to maternal fasting glucose levels and infant birthweight. The rationale builds on evidence that circadian disruption, melatonin suppression, and altered sleep from nighttime light exposure can influence metabolic regulation, potentially affecting fetal growth and pregnancy outcomes.

Researchers recruited pregnant women and assessed multiple factors in the late third trimester, including evening light exposure, sleep, and fasting glucose. Evening blue‐light exposure was quantified using wearable or environmental light measurements, focusing specifically on short‐wavelength (blue) light during the evening and night period rather than broad illuminance alone. Maternal fasting glucose was measured clinically, and infant birthweight was obtained at delivery, allowing the team to explore relationships among light exposure, maternal metabolism, and fetal growth.

The study tested the hypothesis that greater evening blue‐light exposure would be associated with higher maternal fasting glucose and with differences in infant birthweight. Results supported an association between elevated evening blue‐light exposure and higher maternal fasting glucose, suggesting that nighttime spectral composition of light may modulate metabolic status in late pregnancy. Patterns in infant birthweight indicated that maternal evening blue‐light exposure may also be linked to fetal growth outcomes, though the authors note that effect sizes and causality require cautious interpretation.

The authors interpret these findings as evidence that evening short‐wavelength light could be an environmental factor affecting glucose regulation during pregnancy, potentially via circadian and melatonin‐mediated pathways. From a clinical and public health perspective, the work suggests that managing evening light exposure—particularly blue‐rich light from LEDs and screens—might be a low‐cost behavioral lever to support healthier maternal glucose profiles and possibly more favorable birthweight outcomes. The study is notable for integrating light metrics with sleep and metabolic measures in a pregnant cohort, highlighting light as a relevant exposure variable in perinatal research.

The authors acknowledge limitations such as sample size, observational design, and potential residual confounding from lifestyle and environmental factors. They call for controlled interventional studies that manipulate evening spectral content and intensity, as well as larger cohorts to confirm the relationship between blue‐light exposure, maternal glucose, and infant growth. Future work may also explore dose–response relationships, timing windows of greatest sensitivity, and interactions with sleep quality and other circadian stressors.

The research study can be found here.

Image above: Pexels.com

David Shiller

David Shiller is the Publisher of LightNOW, and Senior Business Development Consultant at Capacity Consulting, a North American consulting firm providing business development services to advanced lighting manufacturers. The ALA awarded David the Pillar of the Industry Award. David has been co-chair of the ALA’s Engineering Committee since 2010. David established MaxLite’s OEM component sales into a multi-million dollar division. He invented GU24 lamps while leading ENERGY STAR lighting programs for the US EPA. David has been published in leading lighting publications, including LD+A, enLIGHTenment Magazine, LEDs Magazine, and more.

See Full Bio